Antud taskuhäälingus süvenen genoomika ja geneetika põnevasse maailma. Taskuhäälingus tuleb juttu viimastest läbimurretest DNA-uuringute alal kui ka geenitehnoloogiat ümbritsevatest eetilistest küsimustest ning teadusuudistest. Head kuulamist! genoomiline@gmail.com
GENOOMILINE
Claim This Podcastby GENOOMILINE
5.0(5 reviews)
70 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇪🇪
Podcast Overview
Antud taskuhäälingus süvenen genoomika ja geneetika põnevasse maailma. Taskuhäälingus tuleb juttu viimastest läbimurretest DNA-uuringute alal kui ka geenitehnoloogiat ümbritsevatest eetilistest küsimustest ning teadusuudistest. Head kuulamist! genoomiline@gmail.com
Language
🇪🇪
Publishing Since
2/4/2023
1 verified contact email on file for GENOOMILINE
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 19, 2025
#70 ILMN, PacBio, HIV, 23&me, TRUMP, ESHG2025
<p>(00:26) Illumina esitab patendihagi Element Biosciences'i vastu</p><li><p>(01:51) Geenimutatsioon, mis võimaldab toime tulla vaid nelja tunni unega</p></li><li><p>(03:58) Tuhandeid aastaid vana mutatsioon, mis kaitseb HIV vastu</p></li><li><p>(06:02) Qiagen omandab Genooxi</p></li><li><p>(07:00) Regeneron ostab 23andMe varad pärast pankrotimenetlust</p></li><li><p>(08:12) Illumina tõstab hindu vastuseks tariifidele ja tarneahela survele</p></li><li><p>(09:31) Illumina ja PacBio koondamised</p></li><li><p>(10:28) Trumpi administratsiooni eelarvekava näeb ette NIH rahastuse järsu kärpe</p></li><li><p>(12:01) Pacific Biosciences alandab tuluprognoosi ja jätab short-read sekveneerimise minevikku?</p></li><li><p>(13:22) ESHG 2025 toob Milanos kokku geneetikavaldkonna tipud - Näeme seal! 🙂</p></li>
January 26, 2025
#69 JPM recap, UKB-PPP, SolveRD ja EMBO
(00:29) Illumina: NovaSeq X ja Partnerlus Nvidia'ga (01:50) Pacific Biosciences: Vega ja Revio Sekveneerijad (02:37) Element Biosciences: Uued Partnerlused ja Aviti DxNY genoomilise sõeluuringu potentsiaal vastsündinute haiguste avastamiseks (04:29) Ultima Genomics: Suuremahulised Sekveneerimisprojektid (05:17) Singular Genomics: Deerfield Management'i Ülevõtmine (05:53) Thermo Fisher Scientific: 2024. Aasta Saavutused ja Olinki Omandamine (06:53) Solve-Rare Diseases Consortium: Haruldaste Haiguste Genoomiline Uuesti Analüüs (09:36) Ühendkuningriigi Biopank: Plasmaproteoomide Profileerimise UuringIllumina finantsprognoosi langus ja ettevõtte majanduslik seisund 2024. aastal (12:21) EMBO Installatsioonigrandid: Mari Sepa Uuringud Väikeaju KohtaBio uus sekvenaator Vega
November 10, 2024
#68 2050&vähk, nbWGS, DRAGEN, SPRQ, VEGA
Genoomiline hostid uurivad USA vaatevinklist genoomilist meditsiini arengut, vähijuhtumite kasvu prognoosi, ning avastavad võimalusi võrreldes globaalsete tervishoiusüsteemidega.
70 total episodes available
Deep-dive analytics for GENOOMILINE
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is GENOOMILINE?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.